Latest Details,N-formyl peptide receptors

The n-formyl peptide receptor 2 (FPR2), also known as FPR2/ALX, stands out as a crucial component of the innate immune system. This seven transmembrane G protein-coupled receptor (GPCR) is ubiquitously expressed on various cell types, playing a pivotal role in host defense and inflammation. Initially identified for its ability to bind N-formyl peptides, which are characteristic of bacterial proteins and degraded host cells, FPR2 has since revealed a much broader spectrum of functions, acting as a pattern recognition G protein-coupled receptor (GPCR).

Structure and Function of FPR2

Belonging to the formylpeptide receptor (FPR) subfamily of GPCRs, FPR2 is encoded by a distinct gene located on chromosome 19 in humans. While FPR1 and FPR3 are the other members of the human formyl peptide receptor family, FPR2 is distinguished by its promiscuity and lower affinity for classical N-formyl peptides compared to FPR1. Despite this, FPR2 is a remarkably versatile transmembrane protein capable of recognizing a diverse array of ligands. This versatility is underscored by its ability to bind not only bacterial-derived formyl peptides but also endogenous molecules such as specialized pro-resolving mediators (SPMs) like lipoxin A4 and annexin 1. This interaction with SPMs is particularly significant as it links FPR2 to the resolution of inflammation.

The signaling cascade initiated by FPR2 activation typically involves G protein-coupled receptor pathways, leading to various downstream cellular responses. A significant aspect of FPR2's function is its involvement in the host's defense against bacterial infection and inflammation. Research has demonstrated that FPR2 can induce radical oxygen production in fibroblasts, contributing to the inflammatory response. Furthermore, activation of FPR2 has been shown to efficiently abrogate LPS-induced neuroinflammation in ex vivo models, highlighting its potential in modulating inflammatory processes in the central nervous system.

FPR2 in Inflammatory and Disease Contexts

Emerging evidence positions FPR2 as an emerging modulator of inflammation in the liver. Studies suggest a prominent role of FPRs in regulating the hepatic inflammatory response, particularly after LPS-induced liver injury. The receptor's involvement in inflammatory disorders has spurred interest in developing FPR2 agonists and antagonists as therapeutic agents. For instance, the FPR2 agonist MR-39 has exhibited anti-inflammatory activity in LPS-stimulated organotypic hippocampal cultures, indicating its potential in treating inflammatory conditions. Another notable FPR2 agonist is WKYMVm, which has demonstrated powerful anti-inflammatory effects, including the reduction of lung and spinal cord injury.

Beyond its role in general inflammation, FPR2 has been implicated in various diseases. For example, genetic variations or dysregulation of FPR2 have been associated with conditions like prion disease and Diamond-Blackfan anemia 2. Its role in the immune system extends to macrophages, where FPR2 can influence their function and response to stimuli.

Therapeutic Potential of FPR2

The multifaceted roles of FPR2 in inflammation, host defense, and disease pathogenesis make it a compelling therapeutic target. The development of small-molecule FPR2 agonists has seen significant progress over the past two decades, aiming to harness the receptor's anti-inflammatory and pro-resolving capabilities. Formyl peptide receptor type 2 (FPR2/ALX) activation by ligands like lipoxin A4 is linked to the resolution of inflammation, offering a pathway to dampen chronic inflammatory responses.

The intricate signaling pathways and diverse ligand-binding capabilities of FPR2 are subjects of ongoing research. Understanding the structural basis of ligand binding at the human FPR2 provides critical insights for designing more specific and potent therapeutic agents. As a low affinity receptor for N-formyl peptides and a key player in recognizing various endogenous molecules, FPR2 represents a promising avenue for developing novel treatments for a range of inflammatory and immune-mediated diseases. The comprehensive information available through resources like UniProt further aids in unraveling the complexities of FPR2 and its therapeutic implications.